We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Panelists Say Biosimilars Market Needs Regulatory and Patent Changes to Grow
Panelists Say Biosimilars Market Needs Regulatory and Patent Changes to Grow
Biosimilars experts concluded that fostering the nascent industry would require many of the same elements that originally nurtured the generics industry: educational efforts, regulatory and patent changes, and most importantly, patience.